IDYA (IDEAYA Biosciences) Beginning Cash Position: $113.8 Mil (As of Mar. 2026)


IDYA IDEAYA Biosciences Inc IDYA
54 GF Score
Price $38.26
GF Value $201.69
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is IDEAYA Biosciences Beginning Cash Position?

IDEAYA Biosciences IDYA -5.53% 54 Beginning Cash Position is $113.8 Mil as of Mar. 2026. GuruFocus rates IDYA with a GF Score™ of 54/100 and a GF Value™ of $201.69 (Possible Value Trap). The stock has 6 warning signs investors should review.

IDEAYA Biosciences's Beginning Cash Position for the quarter that ended in Mar. 2026 was $113.8 Mil.

IDEAYA Biosciences's quarterly Beginning Cash Position increased from Sep. 2025 ($115.5 Mil) to Dec. 2025 ($299.7 Mil) but then declined from Dec. 2025 ($299.7 Mil) to Mar. 2026 ($113.8 Mil).

IDEAYA Biosciences's annual Beginning Cash Position increased from Dec. 2023 ($68.7 Mil) to Dec. 2024 ($157.8 Mil) but then declined from Dec. 2024 ($157.8 Mil) to Dec. 2025 ($85.2 Mil).

IDEAYA Biosciences Beginning Cash Position Related Terms

IDEAYA Biosciences Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for IDEAYA Biosciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEAYA Biosciences Beginning Cash Position Chart

IDEAYA Biosciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only 72.14 92.15 68.74 157.78 85.18

IDEAYA Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.18 130.80 115.45 299.73 113.84
IDYA
54GF Score
IDEAYA Biosciences Inc IDYA
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEAYA Biosciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $113.8 Mil mean?
IDEAYA Biosciences (IDYA) has a Beginning Cash Position of $113.8 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on IDEAYA Biosciences and its competitors.
Is IDEAYA Biosciences' Beginning Cash Position too high?
IDEAYA Biosciences' current Beginning Cash Position is $113.8 Mil. Overall, IDEAYA Biosciences has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IDEAYA Biosciences' Beginning Cash Position compare to PBLS and ELVN?
IDEAYA Biosciences' Beginning Cash Position of $113.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on IDEAYA Biosciences and its competitors. IDEAYA Biosciences's current Beginning Cash Position is $113.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEAYA Biosciences stock overvalued right now?
Based on GuruFocus' analysis, IDEAYA Biosciences (IDYA) is currently considered Possible Value Trap. The stock's GF Value™ is $201.69, compared to a current price of $38.26 — trading 81% below its estimated fair value. The current Beginning Cash Position is $113.8 Mil. IDEAYA Biosciences' overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For IDEAYA Biosciences (IDYA), the current Beginning Cash Position is $113.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEAYA Biosciences (IDYA) Overvalued in 2026?

Based on GuruFocus' analysis, IDEAYA Biosciences stock appears to be undervalued. The current stock price of $38.26 is trading 81% below its estimated GF Value™ of $201.69. GuruFocus considers IDEAYA Biosciences to be Possible Value Trap.

Key valuation signals for IDYA:

  • Beginning Cash Position: $113.8 Mil
  • GF Value™: $201.69 vs. price of $38.26 (81% below fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the IDYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEAYA Biosciences Business Description

Other Exchanges 30J:Germany
Address 5000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
54GF Score

Get the complete analysis for IDYA

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$38.26
Price
$201.69
GF Value